Psychiatry AtlasMedication guide · United States

Stimulant medicine

Mixed amphetamine salts (Adderall, Adderall XR)

Generic name
dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate
Brand names
Adderall; Adderall XR
Medication class
Stimulant medicine
Forms covered
Adderall immediate-release tablets; Adderall XR extended-release capsules

Article updated: 2026-10-30 · Sources last checked: 2026-11-05

Medication Safety Alerts

Look-alike / sound-alike name

  • Adderall can be confused with Adderall XR (U.S. official label). These are different release formulations of the same active medication; their names must not be treated as interchangeable.
  • Adderall can be confused with Inderal. Inderal is a historical US brand name.

FDA Boxed Warning

Adderall immediate-release tablets; Adderall XR extended-release capsules.

Adderall and Adderall XR have a high potential for abuse, misuse and addiction. Misuse can cause overdose and death. Assess and monitor risk before and during treatment, and counsel about secure storage and safe disposal.

Mixed amphetamine salts include Adderall tablets and Adderall XR capsules. Brand, release form, age and kidney function affect the dosing plan; these products are distinct from dextroamphetamine alone.

What to expect: Attention or wakefulness can change on the day of a dose.

Warning signs · Medicine forms
Sources last checked:
2026-11-05

What is this medicine used for?

FDA-approved uses

  • ADHD — Age-specific populations, with IR dosing from age 3. Younger-child use requires careful specialist assessment.Adderall immediate-release tablets.
  • ADHD — Adults and children age 6 or older. Distinct XR age and kidney dosing.Adderall XR extended-release capsules.
  • Narcolepsy — Adults and selected children age 6 or older. Not an indication of the selected XR product.Adderall immediate-release tablets.

What should I expect?

Attention or wakefulness can change on the day of a dose. Immediate-release tablets and extended-release capsules cover different parts of the day, and duration varies between people.

Review daily functioning, sleep, appetite and when symptoms return with the prescriber. Do not add late doses to chase a longer effect.

How do I take it safely?

Take the first immediate-release dose on waking; later prescribed doses are spaced through the day, avoiding late evening. Adderall XR is taken in the morning, with or without food. Swallow XR whole or sprinkle all contents onto applesauce and swallow without chewing; do not divide the contents.

The immediate-release and XR age approvals differ, and XR also has kidney-related restrictions. Have the exact product checked before switching. Follow blood pressure, pulse, sleep, appetite, mood, tics and growth in children, with a cardiac and family-history assessment before treatment.

An MAOI within the preceding 14 days is contraindicated. Other medicines affecting serotonin, stomach or urine acidity, or drug breakdown can alter risks. Review pregnancy and breastfeeding. Store securely, never share and avoid unapproved routes or extra doses.

Do not double or take a late catch-up dose. Ask about a planned reduction after regular use; abrupt stopping can cause pronounced fatigue, low mood and sleep changes.

Do not use this product after a known allergy to its active medicine or ingredients; tell the pharmacist about previous medication reactions.

What side effects should I know about?

  • Reduced appetite, insomnia, abdominal discomfort, headache or nervousness.

Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.

Which warning signs need help?

  • The boxed warning covers abuse, misuse and addiction; misuse can cause overdose or death.
  • Seek emergency care for chest pain, fainting, a seizure, severe agitation or suspected overdose. Fever with confusion, diarrhea, tremor or rigid muscles can be serotonin syndrome and needs urgent assessment; severe symptoms are an emergency.
  • Promptly report hallucinations, mania, worsening tics or painful, cold or discolored fingers or toes. Heart disease, increases in blood pressure or pulse and slowed childhood growth need follow-up.
  • Adderall XR is not approved or recommended for ADHD below age 6. Younger children have higher drug exposure and more side effects, including weight loss, with extended-release stimulants. Report weight loss or slowed growth to the prescriber; any change needs a clinician’s plan. Immediate-release age instructions do not apply to this form.

What else should I know to stay safe?

  • Do not use with an MAOI or within 14 days after stopping one, or after product allergy. Serious heart disease needs assessment; medicines affecting serotonin, acidity or drug breakdown require interaction review.
  • Monitor blood pressure, pulse, sleep, appetite, mood, tics and childhood growth. Age approvals differ between immediate- and extended-release products, and XR has kidney-related restrictions. Discuss pregnancy and breastfeeding.
  • Store securely and never share or use an unapproved route. Plan stopping after prolonged use with the prescriber because pronounced fatigue, depression and sleep changes can follow abrupt reduction.

Urgent help and crisis support · Emergency & Crisis Resources (US)

What can help day to day?

  • The same family name does not establish a safe conversion to dextroamphetamine or lisdexamfetamine. The prescriber must check the actual product.
  • Loss of appetite and sleep can undermine a day that otherwise feels more focused. Those trade-offs belong in the treatment review.

How does it work?

Mixed amphetamine salts contain two forms of amphetamine that change the handling of dopamine and norepinephrine, chemical messengers used by nerve cells. They increase messenger release and reduce its return into cells. These actions help describe what the medicine does, although the exact pathway to attention-deficit/hyperactivity disorder (ADHD) symptom improvement is not fully understood.

Explore medication science

How was this medicine developed?

Adderall XR received FDA approval in 2001. Its capsule uses immediate and delayed release of mixed amphetamine salts, extending delivery compared with immediate-release tablets without making every amphetamine product interchangeable.

How do I say the name?

Mixed amphetamine salts: amphetamine: am-FET-a-meen; dextroamphetamine: dex-troe-am-FET-a-meen. Capital letters show the stressed syllable.

Medicine forms and official information

Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.

Sources and References

Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.

  1. Adderall (mixed amphetamine salts) tablets: prescribing information — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: Clinical Pharmacology: Pharmacodynamics and Pharmacokinetics..

  2. Mixed amphetamine salts: FDA approval history
  3. Mixed amphetamine salts: patient medicine information

    Scope: United States; general safety education only.

  4. Adderall XR (mixed amphetamine salts): prescribing information — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: 11 Description; 12.1 Mechanism of Action; 12.3 Pharmacokinetics..

  5. Adderall XR FDA approval history
  6. FDA requires expanded labeling about weight loss risk in patients younger than 6 years taking extended-release stimulants for ADHD
  7. Adderall XR FDA prescribing information
  8. Adderall: Package Insert / Prescribing Information
  9. Lisdexamfetamine: prescribing information
  10. Mixed amphetamine salts: verified neutral parent, PubChem CID 3007
  11. ISMP List of Confused Drug Names
  12. Adderall immediate-release FDA prescribing information (2023)
  13. Frequently Asked Questions about Labeling for Prescription Medicines | FDA
  14. Serotonin syndrome: MedlinePlus Medical Encyclopedia
  15. Monitoring a person during and after antidepressant switching – NHS SPS - Specialist Pharmacy Service – The first stop for professional medicines advice
  16. Schizophrenia
  17. NIMH: Understanding psychosis

Giving medicine safely to children: family guide (PDF, 3 pages)

How information is checked

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top